Built by the people who invented the assay
DrugUptech is a spinout in formation from the School of Biosciences at the University of Kent, founded to turn a research method into a service the industry can use.
From a membrane biophysics lab to a contract research service
The DrugUptech platform grew out of research on how small molecules cross biological membranes, and out of frustration with the tools available to measure it. Existing methods destroyed the cells, required labelled compounds or worked only in artificial membranes.
Over several years the team developed a fluorescent detection system that follows compound accumulation in living cells in real time, then validated it across bacteria, fungi, human cell lines and plant tissue. Pilot studies with industrial partners followed, and the technology now stands at TRL 6.
We operate as a contract research organisation: you send compounds, we run the assays and return decision-ready reports. Incorporation as an independent company is under way with the support of the University of Kent.
Deep technical expertise with growing commercial strength
Matthew Rice
Developed and validated the fluorescence uptake platform during his PhD at Kent. Leads antimicrobial and nutraceutical R&D and day-to-day operations.
Dr Jose Ortega-Roldan
Inventor of the technology and Senior Lecturer in the School of Biosciences, University of Kent. Structural biology and membrane protein drug discovery.
Dr Lorena Varela
Leads plant and agrochemical R&D and market discovery, including uptake assays in plant cells, protoplasts and leaf tissue.
Susanne Schroeder
Advises on commercial strategy, partnerships and the route to market for the service.
Backed by
Pilot studies are ongoing with partners in agrochemical, antimicrobial and pharmaceutical discovery. If you would like to join an early-adopter programme, get in touch.
Talk to the scientists who built the platform
Every project is scoped and run by the founding team.